A study conducted by Piyathilake et al. prior to fortification suggested an increased risk for cervical squamous intraepithelial lesions (SILs) in the presence of the TT or CT genotype of the MTHFR C677T polymorphism [13]. Here, MTHFR is linked to cervical squamous intraepithelial neoplasia.